SCENESSE® provides photoprotection, improves QoL in variegate porphyria 2024 Announcements . Clinical . News . Regulatory 04.03.2024
Appendix 3Z – Final Director’s Interest Notice 2024 Announcements . Financial . News . Regulatory 27.02.2024
CLINUVEL Delivers Increased Revenues, Solid Earnings in December 2023 Half Year 2024 Announcements . Financial . News . Regulatory 22.02.2024
Appendix 4D Half year ended 31 December 2023 2024 Announcements . Financial . News . Regulatory 22.02.2024
Notice of change of interests of substantial holder 2024 Announcements . Financial . News . Regulatory 31.01.2024
Change of Director’s interest notice — Philippe Wolgen 2023 Announcements . Financial . News . Regulatory 27.11.2023
Notification of cessation of securities 2023 Announcements . Financial . News . Regulatory 27.11.2023
Appendix 4G and Corporate Governance Statement 2023 Announcements . Financial . Regulatory 29.08.2023